Iconiq Capital, LLC Astrazeneca PLC Transaction History
Iconiq Capital, LLC
- $3.93 Billion
- Q1 2025
A detailed history of Iconiq Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Iconiq Capital, LLC holds 15,823 shares of AZN stock, worth $1.11 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,823
Previous 14,045
12.66%
Holding current value
$1.11 Million
Previous $920,000
26.3%
% of portfolio
0.03%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.02 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.86 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.51 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.24 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.2 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $218B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...